Costs and benefits of prosthetic vascular surgery
- PMID: 3150842
Costs and benefits of prosthetic vascular surgery
Abstract
For a variety of reasons, primary amputation is often advised in the elderly individual with a severely ischemic leg. Reinforcing this recommendation is the perception that reconstructive arterial surgery in this group is far more expensive than the primary amputation. Living more than only one more year after amputation, professional nursing care cost approaches $100,000. In two recent studies, the cost for patients undergoing primary below the knee amputations plus rehabilitation was almost identical to the mean patient cost for arterial reconstruction. In addition, under the prospective payment systems, substantial financial loss accrues to hospitals caring for these patients.
Similar articles
-
Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia.J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):111S-115S. doi: 10.1016/s1051-0443(95)71259-3. J Vasc Interv Radiol. 1995. PMID: 8770853 Review.
-
[Vascular reconstruction and/or amputation in severely handicapped patients].Langenbecks Arch Chir Suppl Kongressbd. 1996;113:866-9. Langenbecks Arch Chir Suppl Kongressbd. 1996. PMID: 9102009 German.
-
The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein.J Vasc Surg. 1992 Jan;15(1):167-74; discussion 174-5. doi: 10.1067/mva.1992.33676. J Vasc Surg. 1992. PMID: 1728675
-
[Cost-benefit analysis of saving the leg].Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989:617-9. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1989. PMID: 2577606 German.
-
Treatment of chronic critical leg ischaemia--a cost benefit analysis.Ann Chir Gynaecol Suppl. 1997;213:1-142. Ann Chir Gynaecol Suppl. 1997. PMID: 9373713 Review. No abstract available.
Cited by
-
Cost-effective management of diabetic foot ulcers. A review.Pharmacoeconomics. 1997 Jul;12(1):42-53. doi: 10.2165/00019053-199712010-00005. Pharmacoeconomics. 1997. PMID: 10173073 Review.